Revolution Medicines, Inc.
RVMD
Xếp hạng trong cổ phiếu
#600
Revolution Medicines, Inc. is a precision oncology firm operating in the... Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic arsenal, Revolution Medicines is advancing RMC-6291, which selectively inhibits mutated forms of KRASG12C(ON) and NRASG12C(ON). Another promising compound, RMC-6236, specifically targets and inhibits a range of active RAS(ON) variants. Its research efforts also encompass other active RAS inhibitors aimed at KRASG13C(ON) and KRASG12D(ON) mutations. Revolution Medicines has established a collaborative partnership with Sanofi to research and develop SHP2 inhibitors, a collaboration that includes the development of RMC-4630. Established in 2014, Revolution Medicines, Inc. operates from its corporate headquarters situated in Redwood City, California.
Giá cổ phiếu
$187.76
Vốn hóa thị trường
$40.24B
Thay đổi (1 ngày)
-3.35%
Thay đổi (1 năm)
254.40%
Quốc gia
US
Giao dịch Revolution Medicines, Inc. (RVMD)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Revolution Medicines, Inc. (RVMD)
Giá đóng cửa cao nhất: $193.96 vào 2026-10-01
Giá đóng cửa thấp nhất: $30.68 vào 2020-02-01
Giá đóng cửa thấp nhất: $30.68 vào 2020-02-01
Lịch sử giá cổ phiếu của Revolution Medicines, Inc. từ 2020 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 73.05% |
| 2025 | 72.22% |
| 2024 | 75.37% |
| 2023 | 10.12% |
| 2022 | -8.93% |
| 2021 | -38.16% |
| 2020 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $535.97 | 25.69% |
US
|
|
| $190.72 | 610.32% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $889.32 | 9.23% |
NL
|
